학술논문
1066P Extended-dose cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Primary analysis of phase II results
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S886-S887
Subject
Language
ISSN
0923-7534